Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R1GV
|
||||
| Former ID |
DCL001180
|
||||
| Drug Name |
DPX-Survivac
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Ovarian cancer [ICD9: 183; ICD10:C56] | Phase 1/2 | [551020] | ||
| Company |
Immunovaccine
|
||||
| Target and Pathway | |||||
| Target(s) | Baculoviral IAP repeat-containing protein 5 | Target Info | [551020] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| Pathway Interaction Database | Aurora B signaling | ||||
| Validated targets of C-MYC transcriptional activation | |||||
| FOXM1 transcription factor network | |||||
| Aurora A signaling | |||||
| References | |||||